Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of MEDI0382 versus placebo in overweight or obese adults with type 2 diabetes mellitus
2017-002025-38Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jun 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing MEDI0382 with Placebo (2 arms). Primary endpoint: Percentage change in glucose area under the curve. Started Jun 2017; status: completed.
02
Drugs
cotadutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2017-002025-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002025-38.